Assignee
SHENYANG FUYANG PHARMACEUTICAL TECH CO LTD
CN·4 granted patents·5 pending applications·1 citations·filing 2016–2020
Top patents by PatentIndex Score
9 records- 0157US11077126B2Use of carrimycin and pharmaceutically acceptable salts of carrimycin in manufacturing medicament for treating and/or preventing tumorSHENYANG FUYANG PHARMACEUTICAL TECH CO LTD·Filed 2018·Granted Aug 3, 2021·1 cites·14 claims
- 0252US11000708B2Use of carrimycin in Mycobacterium tuberculosis infection resistanceSHENYANG FUYANG PHARMACEUTICAL TECH CO LTD·Filed 2016·Granted May 11, 2021·0 cites·4 claims
- 0350US11413302B2Use of carrimycin or active ingredients thereof and use thereofSHENYANG FUYANG PHARMACEUTICAL TECH CO LTD·Filed 2019·Granted Aug 16, 2022·0 cites·16 claims
- 0442US2024118263A1Target for screening anti-tumor drug, use thereof and screening method thereforSHENYANG FUYANG PHARMACEUTICAL TECH CO LTD·Filed 2020·Application pending·0 cites
- 0541US2023159971A1Spiramycin-producing strain, carrimycin-producing strain, construction method therefor, use thereof and method for increasing product yield thereofSHENYANG FUYANG PHARMACEUTICAL TECH CO LTD·Filed 2019·Application pending·0 cites
- 0636US2020163984A1Use of isovaleryl spiramycin i, ii and/or iii in manufacturing medicament for treating and/or preventing tumor, and medicamentSHENYANG FUYANG PHARMACEUTICAL TECH CO LTD·Filed 2018·Application pending·0 cites
- 0735US2022211735A1Medicament and combination product used for preventing, alleviating and/or treating fibrosis, and use thereofSHENYANG FUYANG PHARMACEUTICAL TECH CO LTD·Filed 2020·Application pending·0 cites
- 0832US10858659B2Biosynthetic gene cluster of carrimycinSHENYANG FUYANG PHARMACEUTICAL TECH CO LTD·Filed 2016·Granted Dec 8, 2020·0 cites·8 claims
- 0932US2020405739A1Mtor inhibitor, pharmaceutical composition and use thereofSHENYANG FUYANG PHARMACEUTICAL TECH CO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHENYANG FUYANG PHARMACEUTICAL TECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →